Psoriatic arthritis and HCV elimination from NZ (GP CME Rotorua)

In this review:

This publication is a summary of two presentations made at the Abbvie Breakfast Session on June 11 as part
of the Rotorua GP CME 2016 meeting. Dr Doug White spoke on the role of primary healthcare providers in
identifying patients with possible psoriatic arthritis early in their disease and making appropriate specialist
referral for such patients, thereby improving time to diagnosis and patient care. Prof Ed Gane presented data
on DAA (direct-acting antiviral) therapies and their ability to provide a cure for chronic HCV (hepatitis C virus)
infection which is well tolerated. Importantly, these regimens are now available in NZ, and in combination
with efforts to prevent disease transmission will be important in the elimination of HCV from NZ.

Download PDF Subscribe